These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5656616)

  • 41. In vivo synergy of vitamin K3 and methotrexate in tumor-bearing animals.
    Gold J
    Cancer Treat Rep; 1986 Dec; 70(12):1433-5. PubMed ID: 3791255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Ultrastructural changes in endothelial cells of blood capillaries of the Walker 256 carcinosarcoma while treated with melatonin].
    Ovsianko EV; Pustovetova MG; Samsonova EN; Ovsianko IaU; Fedina RG; Kulishenko AO; Vinogradov AS
    Vopr Onkol; 2014; 60(2):80-3. PubMed ID: 24919267
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distribution in the lungs of labeled Walker 256 carcinosarcoma cells. An autoradiographic study with tritiated cytidine.
    Cliffton EE; Agostino D; Madden RE; Berechid JN
    Arch Surg; 1971 Sep; 103(3):373-5. PubMed ID: 5569922
    [No Abstract]   [Full Text] [Related]  

  • 44. Walker carcinosarcoma 256 in study of anticancer agents. I. Method for simultaneous assessment of therapeutic value and toxicity.
    Rosenoer VM; Mitchley BC; Roe FJ; Connors TA
    Cancer Res; 1966 Aug; 26(8 Pt 2):937-41. PubMed ID: 5212554
    [No Abstract]   [Full Text] [Related]  

  • 45. A simple method to establish simulated gastric and intestinal cancer in rats by mucosal implantation of Walker tumour.
    Broyn T
    Acta Chir Scand; 1974; 140(6):481-5. PubMed ID: 4428926
    [No Abstract]   [Full Text] [Related]  

  • 46. Ruthenium complex exerts antineoplastic effects that are mediated by oxidative stress without inducing toxicity in Walker-256 tumor-bearing rats.
    Alves de Souza CE; Alves de Souza HM; Stipp MC; Corso CR; Galindo CM; Cardoso CR; Dittrich RL; de Souza Ramos EA; Klassen G; Carlos RM; Correia Cadena SMS; Acco A
    Free Radic Biol Med; 2017 Sep; 110():228-239. PubMed ID: 28629835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of radiation plus endotoxin on the Walker 256 rat carcinosarcoma.
    De los Angeles Contre
    Proc Soc Exp Biol Med; 1967 Mar; 124(3):948-53. PubMed ID: 6023438
    [No Abstract]   [Full Text] [Related]  

  • 48. Ultrastructural changes induced in Walker carcinosarcoma by treatment with dihematoporphyrin ester and light in animals with diabetes mellitus.
    Dima VF; Ionescu MD
    Roum Arch Microbiol Immunol; 2000; 59(1-2):119-30. PubMed ID: 11845470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Kinetic study of the reaction of regional lymph nodes and the spleen to the growth of Walker carcinosarcoma].
    Volodarskaia TA; Erokhin VN
    Izv Akad Nauk SSSR Biol; 1974; (2):289-94. PubMed ID: 4461751
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacological studies of the mechanism of tumor-induced bone marrow cytolysis.
    DiStefano JF; Lysik R; Zucker S
    Cancer Res; 1979 Apr; 39(4):1193-8. PubMed ID: 421203
    [No Abstract]   [Full Text] [Related]  

  • 51. Potentials for the use of heparin in combination with radiation therapy, Experience with ascitic Walker 256 carcinosarcoma in weanling rats.
    Torpie RJ
    J Med; 1974; 5(1):133-48. PubMed ID: 4524856
    [No Abstract]   [Full Text] [Related]  

  • 52. [Changes of the bone following intramedullary transplantation of Walker's carcinosarcoma in rats (author's transl)].
    Shinoara N
    Fukuoka Igaku Zasshi; 1974 May; 65(5):271-86. PubMed ID: 4471768
    [No Abstract]   [Full Text] [Related]  

  • 53. [Kinetics of the change in free radical content during the development of Walker carcinosarcoma and the action of Thio-TEPA].
    Saprin AN; Minenkova EA; Nagler LG; Kaznacheev IuS; Krugliak SA; Krugliakova KE; Emanuél' NM
    Biofizika; 1967; 12(6):1099-103. PubMed ID: 4318224
    [No Abstract]   [Full Text] [Related]  

  • 54. Proliferation of Walker 256 carcinosarcoma cells: effect of whole-body hyperthermia and antitumor agents.
    Lushnikova EL; Ovsyanko EV; Nepomnyashchikh LM; Efremov AV; Morozov DV
    Bull Exp Biol Med; 2011 Nov; 152(1):146-52. PubMed ID: 22803062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sesquiterpene lactones of Moquiniastrum polymorphum subsp. floccosum have antineoplastic effects in Walker-256 tumor-bearing rats.
    Martins GG; Lívero FA; Stolf AM; Kopruszinski CM; Cardoso CC; Beltrame OC; Queiroz-Telles JE; Strapasson RL; Stefanello MÉ; Oude-Elferink R; Acco A
    Chem Biol Interact; 2015 Feb; 228():46-56. PubMed ID: 25616030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alteration of blood-CSF barrier by tumor invasion into the meninges.
    Ushio Y; Shimizu K; Aragaki Y; Arita N; Hayakawa T; Mogami H
    J Neurosurg; 1981 Sep; 55(3):445-9. PubMed ID: 6943305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Some characteristics of the biological action of D, L-1,4-dibromo-1,4-dideoxy-2,3-butanediol].
    Miuller NR; Remizov AL; Belogorodskiĭ VV; Filov VA
    Farmakol Toksikol; 1975; 38(5):590-1. PubMed ID: 1191387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Time factor in evaluating antineoplastic agents].
    Syrkin AB
    Farmakol Toksikol; 1972; 35(1):75-9. PubMed ID: 5011523
    [No Abstract]   [Full Text] [Related]  

  • 59. New nitrosamines.
    Bahner CT; Brotherton D; Brotherton MK
    J Med Chem; 1968 Mar; 11(2):401-2. PubMed ID: 5663646
    [No Abstract]   [Full Text] [Related]  

  • 60. Microangiographic study of Walker 256 carcinosarcoma in rat kidney.
    Oikawa M
    Tohoku J Exp Med; 1974 Jun; 113(2):135-40. PubMed ID: 4439399
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.